sábado , 2 marzo 2024

Lista de mas de 100 estudios sobre efectos adversos de la vacuna contra la hepatitis B

Print Friendly, PDF & Email

Estudios hasta el 2012 Academies of Sciences de EE.UU https://nap.nationalacademies.org/read/13164/chapter/10#494

Adverse Drug Reactions Advisory Committee. 1996. Hepatitis B vaccines—musculoskeletal reactions. Australian Adverse Drug Reactions Bulletin 15(2).

Agmon-Levin, N., Y. Zafrir, Z. Paz, T. Shilton, G. Zandman-Goddard, and Y. Shoenfeld. 2009. Ten cases of systemic lupus erythematosus related to hepatitis B vaccine. Lupus 18(13):1192-1197.

Aherne, P., and M. Collins. 1995. Psoriatic arthropathy. Irish Medical Journal 88(2):72.

Albitar, S., B. Bourgeon, R. Genin, M. Fen-Chong, P. N’Guyen, M. O. Serveaux, H. Atchia, and D. Schohn. 1997. Bilateral retrobulbar optic neuritis with hepatitis B vaccination. Nephrology Dialysis Transplantation 12(10):2169-2170.

Aletaha, D., T. Neogi, A. J. Silman, J. Funovits, D. T. Felson, C. O. Bingham, 3rd, N. S. Birnbaum, G. R. Burmester, V. P. Bykerk, M. D. Cohen, B. Combe, K. H. Costenbader, M. Dougados, P. Emery, G. Ferraccioli, J. M. Hazes, K. Hobbs, T. W. Huizinga, A. Kavanaugh, J. Kay, T. K. Kvien, T. Laing, P. Mease, H. A. Menard, L. W. Moreland, R. L. Naden, T. Pincus, J. S. Smolen, E. Stanislawska-Biernat, D. Symmons, P. P. Tak, K. S. Upchurch, J. Vencovsky, F. Wolfe, and G. Hawker. 2010. 2010 rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis and Rheumatism 62(9):2569-2581.

Allen, M. B., P. Cockwell, and R. L. Page. 1993. Pulmonary and cutaneous vasculitis following hepatitis B vaccination. Thorax 48(5):580-581.

Alter, H. J., R. H. Purcell, J. L. Gerin, W. T. London, P. M. Kaplan, V. J. McAuliffe, J. Wagner, and P. V. Holland. 1977. Transmission of hepatitis B to chimpanzees by hepatitis B surface antigen-positive saliva and semen. Infection and Immunity 16(3):928-933.

Ascherio, A., S. M. Zhang, M. A. Hernan, M. J. Olek, P. M. Coplan, K. Brodovicz, and A. M. Walker. 2001. Hepatitis B vaccination and the risk of multiple sclerosis. New England Journal of Medicine 344(5):327-332.

Ball, R., M. M. Braun, G. T. Mootrey, S. Ellenberg, S. Rastogi, C. Krueger, R. Wise, M. Niu, D. Davis, F. Varricchio, P. Perucci, T. DuVernoy, R. Chen, P. Haber, V. Pool, W. Wattigney, T. Strine, R. Pless, V. Caserta, and G. Evans. 2001. Safety data on meningococcal polysaccharide vaccine from the Vaccine Adverse Event Reporting System. Clinical Infectious Diseases 32(9):1273-1280.

Bancroft, W. H., R. M. Scott, W. T. Watson, and J. J. Karwacki. 1977. Transmission of hepatitis B virus to gibbons by exposure to human saliva containing hepatitis B surface antigen. Journal of Infectious Diseases 135(1):79-85.

Battaglia, A., and R. Valiani. 1992. Description of case of seizure following anti-hepatitis B immunization [in Italian]. Rassegna di Medicina Sperimentale 39(7-9):119-122.

Beasley, R. P., L. Y. Hwang, G. C. Y. Lee, C. C. Lan, C. H. Roan, F. Y. Huang, and C. L. Chen. 1983. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 2(8359):1099-1102.

Begier, E. M., C. A. Langford, M. C. Sneller, R. P. Wise, R. Ball, and V. W. Group. 2004. Polyarteritis nodosa reports to the Vaccine Adverse Event Reporting System (VAERS): Implications for assessment of suspected vaccine-provoked vasculitis. Journal of Rheumatology 31(11):2181-2188.

Bellut, A., E. Laveine, W. Kaise, I. Vivard-Wallee, J. L. Schmutz, and A. Barbaud. 2001. Cutaneous manifestations due to vaccines; Prospective study in Lorraine (France) [in French]. Nouvelles Dermatologiques 20(3):152-155.

Beretta, L., M. Caronni, M. Vanoli, and R. Scorza. 2001. Churg-Strauss vasculitis with brain involvement following hepatitis B vaccination. Clinical and Experimental Rheumatology 19(6):757.
National Academies of Sciences, Engineering, and Medicine. 2012. Adverse Effects of Vaccines: Evidence and Causality. Washington, DC: The National Academies Press. https://doi.org/10.17226/13164.

Biasi, D., A. Carletto, P. Caramaschi, A. Frigo, M. L. Pacor, D. Bezzi, and L. M. Bambara. 1994. Rheumatic manifestations following hepatitis B vaccination. Two case reports [in Italian]. Recenti Progressi in Medicina 85(9):438-440.

Biasi, D., G. De Sandre, L. M. Bambara, A. Carletto, P. Caramaschi, G. Zanoni, and G. Tridente. 1993. A new case of reactive arthritis after hepatitis B vaccination. Clinical and Experimental Rheumatology 11(2):215.

Blumberg, B. S., and H. J. Alter. 1965. A “new” antigen in leukemia sera. Journal of the American Medical Association 191(7):541-546.

Bohlke, K., R. L. Davis, S. M. Marcy, M. M. Braun, F. DeStefano, S. B. Black, J. P. Mullooly, and R. S. Thompson. 2003. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 112(4):815-820.

Bourgeais, A. M., M. X. Dore, A. Croue, C. Leclech, and J. L. Verret. 2003. Cutaneous polyarteritis nodosa following hepatitis B vaccination [in French]. Annales de Dermatologie et de Venereologie 130(2 Pt 1):205-207.

Bracci, M., and A. Zoppini. 1997. Polyarthritis associated with hepatitis B vaccination. British Journal of Rheumatology 36(2):300-301.

Brinar, V. V., and C. M. Poser. 2008. Disseminated encephalomyelitis in adults. Clinical Neurology and Neurosurgery 110(9):913-918.

Bui-Quang, D., E. Thomas, M. Riols, P. Levillain, D. Picaud, A. Sechet, M. Baron, and C. Verove. 1998. Cutaneous vasculitis after hepatitis B vaccination with recombinant vaccine in a renal transplant recipient [in French]. Presse Medicale 27(26):1321-1323.

Cabrera-Gomez, J. A., N. Echazabal-Santana, L. Garcia Gonzalez, A. M. Ramos Cedeno, M. O. Rodriguez Roque, O. Lopez Hernandez, J. A. Cabrera Nunez, J. Gonzalez De La Nuez, and L. Tellez. 2002. A severe episode in a patient with recurrent disseminated acute encephalitis due to vaccination against hepatitis B. For or against vaccination? [in Spanish]. Revista de Neurologia 34(4):358-363.

Cacoub, P., and B. Terrier. 2009. Hepatitis B-related autoimmune manifestations. Rheumatic Diseases Clinics of North America 35(1):125-137.

Caillard, J. F., C. Bastard, and P. Czernichow. 1985. Side effects of hepatitis B vaccination (a study in 1047 subjects at the CHR of Rouen) [in French]. LARC Medical 5(3):129-132.

Casals, J. L., and M. A. Vasquez. 1999. Arthritis after hepatitis B vaccination [in Spanish]. Anales de Medicina Interna 16(11):601-602.

Cathebras, P., O. Cartry, M. H. Lafage-Proust, A. Lauwers, S. Acquart, T. Thomas, and H. Rousset. 1996. Arthritis, hypercalcemia, and lytic bone lesions after hepatitis B vaccination. Journal of Rheumatology 23(3):558-560.

CDC (Centers for Disease Control and Prevention). 1991. Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: Recommendations of the immunization practices advisory committee (ACIP). Morbidity & Mortality Weekly Report 40(RR-13):1-19.

CDC. 2005. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States—recommendations of the Advisory Committee on Immunization Practices (ACIP). Part 1: Immunization of infants, children, and adolescents. Morbidity & Mortality Weekly Report 54(RR16, Suppl. S):1-16, 17-23, 25-31.

CDC. 2006. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States—recommendations of the Advisory Committee on Immunization Practices (ACIP). Part II: Immunization of adults. Morbidity & Mortality Weekly Report 55(RR16, Suppl. S):1-16, 17-33.

CDC. 2010. National, state, and local area vaccination coverage among children aged 19-35 months—United States, 2009. Morbidity & Mortality Weekly Report 59(36):1171-1177.

Chave, T., C. Neal, and R. Camp. 2003. Henoch-Schonlein purpura following hepatitis B vaccination. Journal of Dermatological Treatment 14(3):179-181.
National Academies of Sciences, Engineering, and Medicine. 2012. Adverse Effects of Vaccines: Evidence and Causality. Washington, DC: The National Academies Press. https://doi.org/10.17226/13164.

Cherian, M. P., K. A. Al-Kanani, S. S. Al Qahtani, H. Yesurathinam, A. A. Mathew, V. S. Thomas, A. M. Mathew, and M. A. Abduljabbar. 2010. The rising incidence of type 1 diabetes mellitus and the role of environmental factors—three decade experience in a primary care health center in Saudi Arabia. Journal of Pediatric Endocrinology and Metabolism 23(7):685-695.

Christau, B., and P. Helin. 1987. Reactive arthritis following vaccination against hepatitis B [in Danish]. Ugeskrift for Laeger 149(28).

Cockwell, P., M. B. Allen, and R. Page. 1990. Vasculitis related to hepatitis B vaccine. British Medical Journal 301(6763):1281.

Confavreux, C., S. Suissa, P. Saddier, V. Bourdes, and S. Vukusic. 2001. Vaccinations and the risk of relapse in multiple sclerosis. New England Journal of Medicine 344(5):319-326.

Cooper, G. S., M. A. Dooley, E. L. Treadwell, E. W. St. Clair, and G. S. Gilkeson. 2002. Risk factors for development of systemic lupus erythematosus: Allergies, infections, and family history. Journal of Clinical Epidemiology 55(10):982-989.

Coutinho, R. A., N. Lelie, P. Albrechtvanlent, E. E. Reerinkbrongers, L. Stoutjesdijk, P. Dees, J. Nivard, J. Huisman, and H. W. Reesink. 1983. Efficacy of a heat inactivated hepatitis B vaccine in male-homosexuals: Outcome of a placebo controlled double-blind trial. British Medical Journal 286(6374):1305-1308.

Creange, A., G. Temam, and J. P. Lefaucheur. 1999. Lumbosacral acute demyelinating polyneuropathy following hepatitis B vaccination. Autoimmunity 30(3):143-146.

de Carvalho, J. F., R. M. R. Pereira, and Y. Shoenfeld. 2008. Systemic polyarteritis nodosa following hepatitis B vaccination. European Journal of Internal Medicine 19(8):575-578.

de Carvalho, J. F., and Y. Shoenfeld. 2008. Status epilepticus and lymphocytic pneumonitis following hepatitis B vaccination. European Journal of Internal Medicine 19(5):383-385.

De Keyser, F., J. M. Naeyaert, P. Hindryckx, D. Elewaut, P. Verplancke, I. Peene, M. Praet, and E. Veys. 2000. Immune-mediated pathology following hepatitis B vaccination. Two cases of polyarteritis nodosa and one case of pityriasis rosea-like drug eruption. Clinical and Experimental Rheumatology 18(1):81-85.

Deisenhammer, F., P. Pohl, S. Bosch, and C. Schmidauer. 1994. Acute cerebellar ataxia after immunisation with recombinant hepatitis B vaccine. Acta Neurologica Scandinavica 89(6):462-463.

Delbrel, X., J. Fach, D. Neau, M. Le Bras, and M. Longy Boursier. 1998. Lupus flare-up after hepatitis B vaccination [in French]. Presse Medicale 27(6):260.

DeStefano, F., J. P. Mullooly, C. A. Okoro, R. T. Chen, S. M. Marcy, J. I. Ward, C. M. Vadheim, S. B. Black, H. R. Shinefield, R. L. Davis, and K. Bohlke. 2001. Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. Pediatrics 108(6):E112.

DeStefano, F., T. Verstraeten, L. A. Jackson, C. A. Okoro, P. Benson, S. B. Black, H. R. Shinefield, J. P. Mullooly, W. Likosky, and R. T. Chen. 2003. Vaccinations and risk of central nervous system demyelinating diseases in adults. Archives of Neurology 60(4):504-509.

DeStefano, F., E. S. Weintraub, and R. T. Chen. 2005. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: A prospective study. Neurology 64(7):1317-1318.

DiMiceli, L., V. Pool, J. M. Kelso, S. V. Shadomy, and J. Iskander. 2006. Vaccination of yeast sensitive individuals: Review of safety data in the US Vaccine Adverse Event Reporting System (VAERS). Vaccine 24(6):703-707.

Dobson, S., D. Scheifele, and A. Bell. 1995. Assessment of a universal, school-based hepatitis B vaccination program. Journal of the American Medical Association 274(15):1209-1213.

Drucker, Y., R. A. Prayson, A. Bagg, and L. H. Calabrese. 1997. Lymphocytic vasculitis presenting as diffuse subcutaneous edema after hepatitis B virus vaccine. Journal of Clinical Rheumatology 3(3):158-161.

Duclos, P. 1992. Adverse events after hepatitis B vaccination. Canadian Medical Association Journal 147(7):1023-1026.
National Academies of Sciences, Engineering, and Medicine. 2012. Adverse Effects of Vaccines: Evidence and Causality. Washington, DC: The National Academies Press. https://doi.org/10.17226/13164.

Edmunds, W. J., G. F. Medley, D. J. Nokes, A. J. Hall, and H. C. Whittle. 1993. The influence of age on the development of the hepatitis B carrier state. Proceedings of the Royal Society of London Series B-Biological Sciences 253(1337):197-201.

Elkayam, O., M. Yaron, and D. Caspi. 2002. Safety and efficacy of vaccination against hepatitis B in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 61(7):623-625.

Erguven, M., S. Guven, U. Akyuz, O. Bilgic, and F. Laloglu. 2009. Optic neuritis following hepatitis B vaccination in a 9-year-old girl. Journal of the Chinese Medical Association 72(11):594-597.

Ferrazzi, V., C. Jorgensen, and J. Sany. 1997. Inflammatory joint disease after immunizations. A report of two cases. Revue du Rhumatisme. English Edition 64(4):227-232.

Finielz, P., L. F. Lam-Kam-Sang, and J. Guiserix. 1998. Systemic lupus erythematosus and thrombocytopenic purpura in two members of the same family following hepatitis B vaccine. Nephrology Dialysis Transplantation 13(9):2420-2421.

Fisher, M. A., S. A. Eklund, S. A. James, and X. Lin. 2001. Adverse events associated with hepatitis B vaccine in U.S. children less than six years of age, 1993 and 1994. Annals of Epidemiology 11(1):13-21.

Fonseca, L. F., T. R. Noce, M. L. Teixeira, A. L. Teixeira, Jr., and M. A. Lana-Peixoto. 2003. Early-onset acute transverse myelitis following hepatitis B vaccination and respiratory infection: Case report. Arquivos de Neuro-Psiquiatria 61(2A):265-268.

Fourrier, A., B. Begaud, A. Alperovitch, M. H. Verdier-Taillefer, E. Touze, N. Decker, and J. L. Imbs. 2001. Hepatitis B vaccine and first episodes of central nervous system demyelinating disorders: A comparison between reported and expected number of cases. British Journal of Clinical Pharmacology 51(5):489-490.

Ganem, D., and A. M. Prince. 2004. Mechanisms of disease: Hepatitis B virus infection— natural history and clinical consequences. New England Journal of Medicine 350(11): 1118-1129.

Geier, D. A., and M. R. Geier. 2002a. Hepatitis B vaccination and arthritic adverse reactions: A followup analysis of the Vaccine Adverse Events Reporting System (VAERS) database. Clinical and Experimental Rheumatology 20(1):119.

Geier, D. A., and M. R. Geier. 2002b. A one year followup of chronic arthritis following rubella and hepatitis B vaccination based upon analysis of the Vaccine Adverse Events Reporting System (VAERS) database. Clinical and Experimental Rheumatology 20(6):767-771.

Geier, D. A., and M. R. Geier. 2005. A case-control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity 38(4):295-301.

Geier, M. R., and D. A. Geier. 2000. Arthritic reactions following hepatitis B vaccination: An analysis of the Vaccine Adverse Events Reporting System (VAERS) data from 1990 through 1997. Clinical and Experimental Rheumatology 18(6):789-790.

Geier, M. R., and D. A. Geier. 2002c. Hepatitis B vaccination safety. Annals of Pharmacotherapy 36(3):370-374.

Geier, M. R., and D. A. Geier. 2004. A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: Analysis of the Vaccine Adverse Event Reporting System (VAERS) database and literature review. Clinical and Experimental Rheumatology 22(6):749-755.

Goolsby, P. L. 1989. Erythema-nodosum after Recombivax-HB hepatitis B vaccine. New England Journal of Medicine 321(17):1198-1199.

Grasland, A., F. Le Maitre, J. Pouchot, P. Hazera, C. Bazin, and P. Vinceneux. 1998. Adult Still’s disease after hepatitis A and B vaccination? [in French]. Revue de Medecine Interne 19(2):134-136.
National Academies of Sciences, Engineering, and Medicine. 2012. Adverse Effects of Vaccines: Evidence and Causality. Washington, DC: The National Academies Press. https://doi.org/10.17226/13164.

Grezard, P., M. Chefai, V. Philippot, H. Perrot, and M. Faisant. 1996. Cutaneous lupus erythematosus and buccal aphthosis following hepatitis B vaccination in a 6 year-old boy [in French]. Annales de Dermatologie et de Venereologie 123(10):657-659.

Gross, K., C. Combe, K. Kruger, and M. Schattenkirchner. 1995. Arthritis after hepatitis B vaccination. Report of three cases. Scandinavian Journal of Rheumatology 24(1):50-52.

Guiserix, J. 1996. Systemic lupus erythematosus following hepatitis B vaccine. Nephron 74(2):441.

Hamard, H., P. Hamard, P. Gohier, B. Roussat, D. Doummar, and M. T. Iba-Zizen. 2000. Idiopathic acute optic neuropathies in children [in French]. Bulletin de l’Academie Nationale de Medecine 184(7):1511-1521.

Hartman, S. 1990. Convulsion associated with fever following hepatitis B vaccination. Journal of Paediatrics and Child Health 26(1):65.

Hassan, W., and R. Oldham. 1994. Reiter’s syndrome and reactive arthritis in health care workers after vaccination. British Medical Journal 309(6947):94.

Hernan, M. A., S. S. Jick, M. J. Olek, and H. Jick. 2004. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: A prospective study. Neurology 63(5):838-842.

Herroelen, L., J. de Keyser, and G. Ebinger. 1991. Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine. Lancet 338(8776):1174-1175.

Hocine, M. N., C. P. Farrington, E. Touze, H. J. Whitaker, A. Fourrier, T. Moreau, and P. Tubert-Bitter. 2007. Hepatitis B vaccination and first central nervous system demyelinating events: Reanalysis of a case-control study using the self-controlled case series method. Vaccine 25(31):5938-5943.

Hyams, K. C. 1995. Risks of chronicity following acute hepatitis B virus-infection: A review. Clinical Infectious Diseases 20(4):992-1000.

Iniguez, C., J. A. Mauri, P. Larrode, J. Lopez del Val, I. Jerico, and F. Morales. 2000. Acute transverse myelitis secondary to hepatitis B vaccination [in Spanish]. Revista de Neurologia 31(5):430-432.

Jacobi, D., F. Maillot, C. Hommet, S. Arsene, J. P. Cottier, F. Lamisse, and L. Guillevin. 2005. P-ANCA cranial pachymeningitis: A case report. Clinical Rheumatology 24(2):174-177.

Journe, F., F. Deschamps, and M. L. Germain. 1995. Vascularitis and vaccination against hepatitis B [in French]. Archives des Maladies Professionnelles et de Medecine du Travail 56(1):48.

Kakar, A., and P. K. Sethi. 1997. Guillain Barré syndrome associated with hepatitis B vaccination. Indian Journal of Pediatrics 64(5):710-712.

Karaali-Savrun, F., A. Altintas, S. Saip, and A. Siva. 2001. Hepatitis B vaccine related-myelitis? European Journal of Neurology 8(6):711-715.

Kaygusuz, S., A. K. Erdemoglu, and I. Koksal. 2002. Afebrile convulsion in an adult after recombinant hepatitis B vaccination. Scandinavian Journal of Infectious Diseases 34(4):314-315.

Kerleau, J. M., H. Levesque, G. Lair, F. Lecomte, O. Carrara, and H. Courtois. 1997. Is hepatitis B vaccination a new cause of necrotizing vasculitis? [in French]. Revue de Medecine Interne 18(6):491-492.

Khamaisi, M., Y. Shoenfeld, and H. Orbach. 2004. Guillain-Barré syndrome following hepatitis B vaccination. Clinical and Experimental Rheumatology 22(6):767-770.

Konstantinou, D., C. Paschalis, T. Maraziotis, P. Dimopoulos, H. Bassaris, and A. Skoutelis. 2001. Two episodes of leukoencephalitis associated with recombinant hepatitis B vaccination in a single patient. Clinical Infectious Diseases 33(10):1772-1773.

Koziel, M. J., and C. L. Thio. 2010. Hepatitis B virus and hepatitis delta virus. In Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 7th ed. 2 vols. Vol. 2, edited by G. L. Mandell, J. E. Bennett, and R. Dolin. Philadelphia, PA: Churchill Livingstone Elsevier. Pp. 2059-2086.
National Academies of Sciences, Engineering, and Medicine. 2012. Adverse Effects of Vaccines: Evidence and Causality. Washington, DC: The National Academies Press. https://doi.org/10.17226/13164.

Krugman, S. 1974. Viral-hepatitis and hepatitis B antigen—recent advances. Postgraduate Medical Journal 50(584):327-333.

Krugman, S., and J. P. Giles. 1973. Viral-hepatitis, type B (MS-2-strain)—further observations on natural-history and prevention. New England Journal of Medicine 288(15):755-760.

Krugman, S., L. R. Overby, I. K. Mushahwar, C. M. Ling, G. G. Frosner, and F. Deinhardt. 1979. Viral-hepatitis, type-B—studies on natural-history and prevention reexamined. New England Journal of Medicine 300(3):101-106.

Le Goff, P., P. Fauquert, P. Youinou, and S. Hoang. 1988. Periarteritis nodosa following immunization against hepatitis B [in French]. Presse Medicale 17(34):1763.

Le Goff, P., P. Fauquert, P. Youinou, and S. Hoang. 1991. Periarteritis nodosa (PAN) following vaccine against hepatitis B [in French]. Rhumatologie 43(3):79.

Le Hello, C., P. Cohen, M. G. Bousser, P. Letellier, and L. Guillevin. 1999. Suspected hepatitis B vaccination related vasculitis. Journal of Rheumatology 26(1):191-194.

Lewis, E., H. R. Shinefield, B. A. Woodruff, S. B. Black, F. Destefano, R. T. Chen, and R. Ensor. 2001. Safety of neonatal hepatitis B vaccine administration. Pediatric Infectious Disease Journal 20(11):1049-1054.

Llobat Estelles, T., M. J. Benlloch Muncharaz, L. Santos Serrano, J. M. Paricio Talayero, J. Martin Ruano, and M. Grieco Burucua. 1995. Hepatitis B vaccine associated with erythema nodosum. A case report [in Spanish]. Anales Espanoles de Pediatria 42(2):149.

Lunn, E. R., B. J. Hoggarth, and W. J. Cook. 2000. Prolonged hepatitis B surface antigenemia after vaccination. Pediatrics 105(6):E81.

Mahassin, F., J. P. Algayres, J. Valmary, H. Bili, G. Coutant, D. Bequet, and J. P. Daly. 1993. Acute myelitis following hepatitis B vaccination [in French]. Presse Medicale 22(40):1997-1998.

Maillefert, J. F., P. Farge, M. P. Gazet-Maillefert, and C. Tavernier. 1997. Mental nerve neuropathy as a result of hepatitis B vaccination. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, & Endodontics 83(6):663-664.

Maillefert, J. F., J. Sibilia, E. Toussirot, E. Vignon, J. P. Eschard, B. Lorcerie, R. Juvin, N. Parchin-Geneste, C. Piroth, D. Wendling, J. L. Kuntz, C. Tavernier, and P. Gaudin. 1999. Rheumatic disorders developed after hepatitis B vaccination. Rheumatology 38(10): 978-983.

Maillefert, J. F., C. Tavernier, J. Sibilia, and E. Vignon. 2000. Exacerbation of systemic lupus erythematosus after hepatitis B vaccination: Comment on the article by Battafarano et al. and the letter by Senecal et al. Arthritis and Rheumatism 43(2):468-469.

Mamoux, V., and C. Dumont. 1994. Systemic lupus erythematosus and vaccination against hepatitis B virus [in French]. Archives de Pediatrie 1(3):307-308.

Manna, R., A. De Santis, A. Oliviero, A. Carnevale, S. Caputo, M. Pahor, A. Laudisio, and G. Gasbarrini. 1996. Leukoencephalitis after recombinant hepatitis B vaccine. Journal of Hepatology 24(6):764-765.

Masse, I., and M. C. Descoffres. 1998. Hypersensitivity vasculitis after hepatitis B vaccination [in French]. Presse Medicale 27(20):965-966.

Mast, E. E., and J. W. Ward. 2008. Chapter 13. Hepatitis B vaccines. In Vaccines, edited by S. A. Plotkin, W. A. Orenstein, and P. A. Offit. Philadelphia, PA: Saunders/Elsevier.

Mathieu, E., O. Fain, and A. Krivitzky. 1996. Cryoglobulinemia after hepatitis B vaccination. New England Journal of Medicine 335(5):355.

McLean, A. A., M. R. Hilleman, W. J. McAleer, and E. B. Buynak. 1983. Summary of worldwide clinical-experience with H-B-Vax (B, MSD). Journal of Infection 7(Suppl. 1):95-104.

McMahon, B. J., W. L. M. Alward, D. B. Hall, W. L. Heyward, T. R. Bender, D. P. Francis, and J. E. Maynard. 1985. Acute hepatitis B virus-infection: Relation of age to the clinical expression of disease and subsequent development of the carrier state. Journal of Infectious Diseases 151(4):599-603.
National Academies of Sciences, Engineering, and Medicine. 2012. Adverse Effects of Vaccines: Evidence and Causality. Washington, DC: The National Academies Press. https://doi.org/10.17226/13164.

Mikaeloff, Y., G. Caridade, S. Assi, M. Tardieu, and S. Suissa. 2007a. Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination. Brain 130(4):1105-1110.

Mikaeloff, Y., G. Caridade, M. Rossier, S. Suissa, and M. Tardieu. 2007b. Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis. Archives of Pediatrics & Adolescent Medicine 161(12):1176-1182.

Mikaeloff, Y., G. Caridade, S. Suissa, and M. Tardieu. 2009. Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology 72(10):873-880.

Miron, D., D. Fink, and P. J. Hashkes. 2003. Kawasaki disease in an infant following immunisation with hepatitis B vaccine. Clinical Rheumatology 22(6):461-463.

Niu, M. T., D. M. Davis, and S. Ellenberg. 1996. Recombinant hepatitis B vaccination of neonates and infants: Emerging safety data from the Vaccine Adverse Event Reporting System. Pediatric Infectious Disease Journal 15(9):771-776.

Payne, D. C., C. E. Rose, J. Kerrison, A. Aranas, S. Duderstadt, and M. M. McNeil. 2006. Anthrax vaccination and risk of optic neuritis in the United States military, 1998-2003. Archives of Neurology 63(6):871-875.

Peng, M. M., and H. Jick. 2004. A population-based study of the incidence, cause, and severity of anaphylaxis in the United Kingdom. Archives of Internal Medicine 164(3):317-319.

Pirmohamed, M., and P. Winstanley. 1997. Hepatitis B vaccine and neurotoxicity. Postgraduate Medical Journal 73(861):462-463.

Planchamp, F., K. A. Nguyen, T. Vial, S. Nasri, E. Javouhey, Y. Gillet, B. Ranchin, F. Villard, D. Floret, P. Cochat, F. Gueyffier, and B. Kassai. 2009. Active drug monitoring of adverse drug reactions in pediatric emergency department [in French]. Archives de Pediatrie 16(2):106-111.

Poirriez, J. 2004. A preliminary experiment of absorption of antinuclear antibodies by the hepatitis B vaccine components, in a case of neurolupus. Vaccine 22(23-24):3166-3168.

Polish, L. B., C. N. Shapiro, F. Bauer, P. Klotz, P. Ginier, R. R. Roberto, H. S. Margolis, and M. J. Alter. 1992. Nosocomial transmission of hepatitis B virus association with the use of spring-loaded fingerstick device. New England Journal of Medicine 326(11):721-725.

Pope, J. E., A. Stevens, W. Howson, and D. A. Bell. 1998. The development of rheumatoid arthritis after recombinant hepatitis B vaccination. Journal of Rheumatology 25(9): 1687-1693.

Prince, A. M. 1968. An antigen detected in the blood during the incubation period of serum hepatitis. Proceedings of the National Academy of Sciences of the United States of America 60(3):814-821.

Pritchard, J., R. Mukherjee, and R. A. C. Hughes. 2002. Risk of relapse of Guillain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following immunization. Journal of Neurology, Neurosurgery, and Psychiatry 73(3):348-349.

Purcell, R. H., and J. L. Gerin. 1975. Hepatitis B subunit vaccine: Preliminary report of safety and efficacy tests in chimpanzees. American Journal of the Medical Sciences 270(2):395-399.

Ramagopalan, S. V., W. Valdar, D. A. Dyment, G. C. Deluca, I. M. Yee, G. Giovannoni, G. C. Ebers, and A. D. Sadovnick. 2009. Association of infectious mononucleosis with multiple sclerosis. Neuroepidemiology 32(4):257-262.

Renard, J. L., J. S. Guillamo, J. M. Ramirez, H. Taillia, D. Felten, and Y. Buisson. 1999. Acute cervical transverse myelitis after anti-hepatitis B vaccination: Time course of anti-HBs antibodies [in French]. Presse Medicale 28(24):1290-1292.

Rogalewski, A., J. Kraus, M. Hasselblatt, C. Kraemer, and W. R. Schabitz. 2007. Improvement of advanced postvaccinal demyelinating encephalitis due to plasmapheresis. Neuropsychiatric Disease and Treatment 3(6):987-991.
National Academies of Sciences, Engineering, and Medicine. 2012. Adverse Effects of Vaccines: Evidence and Causality. Washington, DC: The National Academies Press. https://doi.org/10.17226/13164.

Rogerson, S. J., and F. J. Nye. 1990. Hepatitis B vaccine associated with erythema nodosum and polyarthritis. British Medical Journal 301(6747):345.

Roussat, B., P. Gohier, D. Doummar, M. T. Iba-Zizen, V. Barbat, D. Jarry, E. A. Cabanis, H. Hamard, and J. P. Nordmann. 2001. Acute optic neuritis in children: Clinical features and treatment. A study of 20 cases (28 eyes) [in French]. Journal Francais d Ophtalmologie 24(1):36-44.

Saadoun, D., P. Cacoub, D. Mahoux, A. Sbai, and J. C. Piette. 2001. Vasculitis complicating vaccination: A report of three cases [in French]. Revue de Medecine Interne 22(2):172-176.

Sadovnick, A. D., and D. W. Scheifele. 2000. School-based hepatitis B vaccination programme and adolescent multiple sclerosis. Lancet 355(9203):549-550.

Sahlberg, A. S., K. Granfors, and M. A. Penttinen. 2009. HLA-b27 and host-pathogen interaction. Advances in Experimental Medicine and Biology 649:235-244.

Santoro, D., M. Stella, G. Montalto, and S. Castellino. 2007. Lupus nephritis after hepatitis B vaccination: An uncommon complication. Clinical Nephrology 67(1):61-63.

Schessl, J., B. Luther, J. Kirschner, G. Mauff, and R. Korinthenberg. 2006. Infections and vaccinations preceding childhood Guillain-Barré syndrome: A prospective study. European Journal of Pediatrics 165(9):605-612.

Scott, R. M., R. Snitbhan, W. H. Bancroft, H. J. Alter, and M. Tinpalapong. 1980. Experimental transmission of hepatitis B virus by semen and saliva. Journal of Infectious Diseases 142(1):67-71.

Sebag, O., G. Bolla, B. Bebin, and F. Sebag. 1998. Exacerbation of chronic juvenile arthritis induced by hepatitis B vaccination [in French]. Archives de Pediatrie 5(9):1046.

Senecal, J. L., C. Bertrand, and F. Coutlee. 1999. Severe exacerbation of systemic lupus erythematosus after hepatitis B vaccination and importance of pneumococcal vaccination in patients with autosplenectomy: Comment on the article by Battafarano et al. Arthritis & Rheumatism 42(6):1307-1308.

Senejoux, A., D. Roulot, C. Belin, L. Tsakiris, J. Rautureau, and T. Coste. 1996. Acute myelitis after immunization against hepatitis B with recombinant vaccine [in French]. Gastroenterologie Clinique et Biologique 20(4):401-402.

Seti, N. K., R. Reddi, I. Anand, and P. K. Sethi. 2002. Gulliane Barré syndrome following vaccination with hepatitis B vaccine. Journal of the Association of Physicians of India 50:989.

Shapiro, C. N. 1993. Epidemiology of hepatitis B. Pediatric Infectious Disease Journal 12(5): 433-437.

Sieper, J. 2001. Pathogenesis of reactive arthritis. Current Rheumatology Reports 3(5):412-418.

Sikora, A., H. Brozik, D. Chlebna-Sokol, D. Kardas-Sobantka, M. Biernacka, E. Smolewska, and E. Polakowska. 2000. Vaccination against virus hepatitis B in children with connective tissue diseases part I. Safety of vaccination against hepatitis type B in children with chronic juvenile arthritis and other connective tissue diseases [in Polish]. Przeglad Pediatryczny 30(4):292-297.

Sinsawaiwong, S., and P. Thampanitchawong. 2000. Guillain-Barré syndrome following recombinant hepatitis B vaccine and literature review. Journal of the Medical Association of Thailand 83(9):1124-1126.

Souayah, N., A. Nasar, M. F. K. Suri, and A. I. Qureshi. 2007. Guillain-Barré syndrome after vaccination in United States a report from the CDC/FDA Vaccine Adverse Event Reporting System. Vaccine 25(29):5253-5255.

Souayah, N., A. Nasar, M. F. K. Suri, and A. I. Qureshi. 2009. Guillain-Barré syndrome after vaccination in United States: Data from the Centers for Disease Control and Prevention/ Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005). Journal of Clinical Neuromuscular Disease 11(1):1-6.
National Academies of Sciences, Engineering, and Medicine. 2012. Adverse Effects of Vaccines: Evidence and Causality. Washington, DC: The National Academies Press. https://doi.org/10.17226/13164.

Soubeyrand, B., F. Boisnard, M. Bruel, H. Debois, D. Delattre, A. Gauthier, S. Soum, and C. Thebault. 2000. Central nervous system demyelinating disease following hepatitis B vaccination with GenHevac B. Review of ten years of spontaneous notifications (1989-1998) [in French]. Presse Medicale 29(14):775-780.

Soubrier, M., J. J. Dubost, C. Bielsa, J. M. Ristori, and J. L. Bussiere. 1997. Erosive polyarthritis triggered by vaccination against hepatitis B [in French]. Presse Medicale 26(2):75.

Stewart, O., B. Chang, and J. Bradbury. 1999. Simultaneous administration of hepatitis B and polio vaccines associated with bilateral optic neuritis. British Journal of Ophthalmology 83(10):1200-1201.

Tartaglino, L. M., T. Heiman-Patterson, D. P. Friedman, and A. E. Flanders. 1995. MR imaging in a case of postvaccination myelitis. American Journal of Neuroradiology 16(3):581-582.

Terney, D., S. Beniczky, P. Barsi, I. Kondakor, J. Perenyi, A. Faludi, M. Szapper, and L. Vecsei. 2006. Multiple sclerosis after hepatitis B vaccination in a 16-year-old patient. Chinese Medical Journal 119(1):77-79.

Thivolet, C., B. Vialettes, C. Boitard, and J. Bringer. 1999. No evidence that anti hepatitis B vaccine causes insulin dependent diabetes [in French]. Diabetes and Metabolism 25(5):441-445.

Toivanen, A., and P. Toivanen. 2000. Reactive arthritis. Current Opinion in Rheumatology 12(4):300-305.

Tourbah, A., O. Gout, R. Liblau, O. Lyon-Caen, C. Bougniot, M. T. Iba-Zizen, and E. A. Cabanis. 1999. Encephalitis after hepatitis B vaccination: Recurrent disseminated encephalitis or MS? Neurology 53(2):396-401.

Touze, E., A. Fourrier, C. Rue-Fenouche, V. Ronde-Oustau, I. Jeantaud, B. Begaud, and A. Alperovitch. 2002. Hepatitis B vaccination and first central nervous system demyelinating event: A case-control study. Neuroepidemiology 21(4):180-186.

Touze, E., O. Gout, M. H. Verdier-Taillefer, O. Lyon-Caen, and A. Alperovitch. 2000. First episode of central nervous system demyelination and hepatitis B vaccination: A pilot case control study [in French]. Revue Neurologique 156(3):242-246.

Treves, R., L. Lacoste, D. Bontoux, E. Pitrou, P. Bertin, and C. Bonnet. 1997. Erosive nodular rheumatoid arthritis triggered by hepatitis B vaccination [in French]. Presse Medicale 26(14):670.

Tsai, J. F., H. S. Margolis, J. E. Jeng, M. S. Ho, W. Y. Chang, M. Y. Hsieh, Z. Y. Lin, and J. H. Tsai. 1998. Immunoglobulin- and hepatitis B surface antigen-specific circulating immune complexes in chronic hepatitis B virus infection. Clinical Immunology and Immunopathology 86(3):246-251.

Tudela, P., S. Marti, and J. Bonal. 1992. Systemic lupus erythematosus and vaccination against hepatitis B. Nephron 62(2):236.

Tuohy, P. G. 1989. Guillain-Barré syndrome following immunisation with synthetic hepatitis B vaccine. New Zealand Medical Journal 102(863):114-115.

Vanoli, M., D. Gambini, and R. Scorza. 1998. A case of Churg-Strauss vasculitis after hepatitis B vaccination. Annals of the Rheumatic Diseases 57(4):256-257.

Vautier, G., and J. E. Carty. 1994. Acute sero-positive rheumatoid arthritis occurring after hepatitis vaccination. British Journal of Rheumatology 33(10):991.

Ventura, F., H. Antunes, C. Brito, F. Pardal, T. Pereira, and A. P. Vieira. 2009. Cutaneous polyarteritis nodosa in a child following hepatitis B vaccination. European Journal of Dermatology 19(4):400-401.

Verstraeten, T., D. Descamps, M. P. David, T. Zahaf, K. Hardt, P. Izurieta, G. Dubin, and T. Breuer. 2008. Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines. Vaccine 26(51):6630-6638.
National Academies of Sciences, Engineering, and Medicine. 2012. Adverse Effects of Vaccines: Evidence and Causality. Washington, DC: The National Academies Press. https://doi.org/10.17226/13164.

Vital, C., A. Vital, G. Gbikpi-Benissan, M. Longy-Boursier, M. T. Climas, Y. Castaing, M. H. Canron, M. Le Bras, and K. Petry. 2002. Postvaccinal inflammatory neuropathy: Peripheral nerve biopsy in 3 cases. Journal of the Peripheral Nervous System 7(3):163-167.

Voigt, U., U. Baum, W. Behrendt, S. Hegemann, C. Terborg, and J. Strobel. 2001. Neuritis of the optic nerve after vaccinations against hepatitis A, hepatitis B and yellow fever [in German]. Klinische Monatsblatter fur Augenheilkunde 218(10):688-690.

Wu, Z., H. Wu, and Q. Wang. 1999. A case-control study on Guillain-Barré syndrome in children of north China [in Chinese]. Zhonghua Yufang Yixue Zazhi 33(5):279-281.

Yang, Y., S. Sujan, F. Sun, Y. Zhang, Y. Jiang, J. Song, J. Qin, and X. Wu. 2006. Acute metabolic crisis induced by vaccination in seven Chinese patients. Pediatric Neurology 35(2):114-118.

Zaas, A., P. Scheel, A. Venbrux, and D. B. Hellmann. 2001. Large artery vasculitis following recombinant hepatitis B vaccination: 2 cases. Journal of Rheumatology 28(5):1116-1120.

Zipp, F., J. G. Weil, and K. M. Einhaupl. 1999. No increase in demyelinating diseases after hepatitis B vaccination. Nature Medicine 5(9):964-965.
National Academies of Sciences, Engineering, and Medicine. 2012. Adverse Effects of Vaccines: Evidence and Causality. Washington, DC: The National Academies Press. https://doi.org/10.17226/13164.